Changing utilization of cardiovascular drugs during the course of Alzheimer's disease

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F20%3A43919430" target="_blank" >RIV/00216208:11120/20:43919430 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.1016/j.ijcard.2019.11.135" target="_blank" >https://doi.org/10.1016/j.ijcard.2019.11.135</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ijcard.2019.11.135" target="_blank" >10.1016/j.ijcard.2019.11.135</a>

Result language
angličtina
Original language name
Changing utilization of cardiovascular drugs during the course of Alzheimer's disease
Original language description
The relationship between cardiovascular diseases (CVD) and cognitive disorders, such as Alzheimer's disease (AD), the most common type of dementia, has been recently receiving major interest. This interest is focused around the role of cardiovascular risk factors and CVD in the etiology of AD, implying that their improved prevention and treatment may serve as a potential strategy to decrease the incidence of AD. Additionally, management of CVD in patients with AD is complicated by lacking clinical guidelines, as older individuals with conditions such as AD are largely excluded from randomized controlled trials.
Czech name
—
Czech description
—

Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)